In Brief: AHCPR PSA study
This article was originally published in The Gray Sheet
AHCPR PSA study: Agency for Health Care Policy and Research is seeking information on prostate-specific antigen test utility, costs, specific indications and appropriate patient population for a review of past, current and planned research related to PSA testing. According to a Dec. 22 Federal Register notice, AHCPR plans to make a recommendation following completion of the assessment to the Health Care Financing Administration regarding a Medicare coverage policy for the test...
You may also be interested in...
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.